Israel Deutch

Columbia University Irving Medical Center

Papers

1

Total Citations

6

H-Index

1

About

Israel Deutch is a urologic oncologist whose research focuses on optimizing surgical outcomes for prostate cancer, particularly through comparative effectiveness studies of robot-assisted versus open surgical techniques. His most cited work examines biochemical progression risk in men with positive surgical margins after radical prostatectomy, contributing critical evidence to the debate on minimally invasive surgery's oncologic equivalence. Deutch's research addresses the nuanced differences in extirpation techniques between robot-assisted and open retropubic approaches, helping to clarify whether technological advances compromise cancer control. With 6 citations on his landmark 2013 study, his work has informed clinical decision-making for surgeons weighing perioperative benefits against long-term oncologic risks. Deutch's contributions are particularly valuable for urologists and trainees navigating the adoption of robotic platforms, as his findings underscore the importance of surgical technique standardization. His scholarship bridges the gap between technological innovation and evidence-based practice, making him a respected voice in urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Robot-Assisted and Open Retropubic Radical Prostatectomy for Risk of Biochemical Progression in Men with Positive Surgical Margins
6 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Columbia University Irving Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago